Chemoinformaics analysis of FERNA-7,9(11)-DIENE
| Molecular Weight | 408.714 | nRot | 1 |
| Heavy Atom Molecular Weight | 360.33 | nRig | 25 |
| Exact Molecular Weight | 408.376 | nRing | 5 |
| Solubility: LogS | -7.168 | nHRing | 0 |
| Solubility: LogP | 8.268 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 82.1061 |
| nHD | 0 | BPOL | 48.1539 |
| QED | 0.406 |
| Synth | 4.77 |
| Natural Product Likeliness | 3.239 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.867 |
| Pgp-sub | 0 |
| HIA | 0.034 |
| CACO-2 | -4.997 |
| MDCK | 0.00000417 |
| BBB | 0.029 |
| PPB | 0.979742 |
| VDSS | 2.947 |
| FU | 0.0178235 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.433 |
| CYP2c19-inh | 0.091 |
| CYP2c19-sub | 0.98 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.422 |
| CYP2d6-inh | 0.126 |
| CYP2d6-sub | 0.549 |
| CYP3a4-inh | 0.325 |
| CYP3a4-sub | 0.883 |
| CL | 13.338 |
| T12 | 0.009 |
| hERG | 0.518 |
| Ames | 0.009 |
| ROA | 0.048 |
| SkinSen | 0.93 |
| Carcinogencity | 0.072 |
| EI | 0.078 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.593 |
| Antiviral | No |
| Prediction | 0.528813 |